|
| 產地 | 進口、國產 |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS10893 |
| 應用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-RNF139 |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human RNF139 |
抗體的生物素化標記實驗要點：
1. 環(huán)指蛋白139抗體費用 如在反應混合液中有疊氮鈉或游離氨基存在,會抑制標記反應。因此,蛋白質在反應前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質之間的分子比按蛋白質表面的ε-氨基的密度會有所不同,選擇不當則影響標記的效率,應先用幾個不同的分子比來篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結合位點可能因此被封閉,導致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等；
5.當游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結合力或活性；
6.生物素還可能與不同的功能基團,如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價結合；
7.交聯(lián)反應后,應充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結合產生競爭作用；
8.在細胞的熒光標記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細胞可導致高本底。
產品訂購信息：
英文名稱 Anti-RNF139
中文名稱 環(huán)指蛋白139抗體費用
別 名 HRCA1; RCA1; Ring finger protein 139; TRC8; RN139_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep
產品類型 一抗
研究領域 免疫學 信號轉導
蛋白分子量 predicted molecular weight: 76kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human RNF139
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
環(huán)指蛋白139抗體費用 產品應用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 The protein encoded by this gene is a multi-membrane spanning protein containing a RING-H2 finger. This protein is located in the endoplasmic reticulum, and has been shown to possess ubiquitin ligase activity. This gene was found to be interrupted by a t(3:8) translocation in a family with hereditary renal and non-medulary thyroid cancer. Studies of the Drosophila counterpart suggested that this protein may interact with tumor suppressor protein VHL, as well as with COPS5/JAB1, a protein responsible for the degradation of tumor suppressor CDKN1B/P27KIP.
Function : E3-ubiquitin ligase; acts as a negative regulator of the cell proliferation through mechanisms involving G2/M arrest and cell death. Required for MHC class I ubiquitination in cells expressing the cytomegalovirus protein US2 before dislocation from the endoplasmic reticulum (ER). Affects SREBP processing by hindering the SREBP/SCAP complex translocation from the ER to the Golgi, thereby reducing SREBF2 target gene expression. Required for INSIG1 ubiquitination. May be required for EIF3 complex ubiquitination. May function as a signaling receptor.
Subunit : Interacts with VHL. Interacts with MHC class I and HM13. Component of SCAP/SREBP complex composed of SREBF2, SCAP and RNF139; the complex hampers the interaction between SCAP and SEC24B, thereby reducing SREBF2 proteolytic processing. Interacts with SREBF2 (via C-terminus domain). Interacts with SCAP; the interaction inhibits the interaction of SCAP with SEC24B and hampering the ER to Golgi transport of the SCAP/SREBP complex. Interacts with SEC24B. Interacts with INSIG1 and INSIG2. Interacts with EIF3F and EIF3H; the interaction leads to protein translation inhibitions in a ubiquitination-dependent manner.
Subcellular Location : Endoplasmic reticulum membrane; Multi-pass membrane protein.
Tissue Specificity : Highly expressed in testis, placenta and adrenal gland. Moderate expression in heart, brain, liver, skeletal muscle and pancreas, and low expression in lung and kidney.
Post-translational modifications : Autoubiquitinated. Ubiquitination is induced by sterol and leads to ist degradation via the ubiquitin-proteasome pathway.
DISEASE : Defects in RNF139 may be a cause of renal cell carcinoma (RCC) [MIM:144700]. It is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. It is subclassified into clear cell renal carcinoma (non-papillary carcinoma), papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma with medullary carcinoma of the kidney, and unclassified renal cell carcinoma. Note=A chromosomal aberration involving RNF139 has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation (3;8)(q14.2;q24.1) with FHIT. RNF139 is found to be fused to FHIT and disrupted within the sterol-sensing domain. In contrast, the FHIT coding region is maintained and expressed. Sporadic cases of renal carcinoma, where an acquired mutation in RNF139 results in the duplication of 12 nucleotides in the 5'-UTR, has also been identified.
Similarity : Contains 1 RING-type zinc finger.
抗體的鑒定：
1）環(huán)指蛋白139抗體費用 抗體的效價鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應,瓊脂擴散試驗,酶聯(lián)免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴散試驗來鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應抗原或近似抗原物質的識別能力?？贵w的特異性高,它的識別能力就強。衡量特異性通常以交叉反應率來表示。交叉反應率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結合率,求出各自在IC50時的濃度,并按公式計算交叉反應率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質的交叉反應率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結合位點與抗原決定簇之間立體構型的合適度決定的。有助于維持抗原抗體復合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。
Irna(Human Immune RNA) ELISA Kit 人免疫核糖核酸Multi-class antibodies規(guī)格： 48T
Anti-phospho-FSCN1(Ser39) 磷酸化纖維束蛋白同源物1抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh Histone H3 (Di Methyl K4) 二甲基化組蛋白H3K4抗體 規(guī)格 0.1ml
SRP(Human signal recognization particle antibody) ELISA Kit 人抗信號識別顆粒抗體 96T
recPEP 英文名稱： 重組豬病毒結構蛋白抗體 0.1ml
COMMD3 英文名稱： 銅代謝結構域蛋白3抗體 0.2ml
Anti-phospho-FSCN1(Ser39) 磷酸化纖維束蛋白同源物1抗體Multi-class antibodies規(guī)格： 0.1ml
Anti-RRM1/FITC 熒光素標記抗核糖核苷酸還原酶1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
IGF-II( Insulin-like Growth Factor-II ) 樣生長因子-II(抗原)Multi-class antibodies規(guī)格： 0.5mg
黑素瘤抗原-1抗體 Anti-MAGE-1/HLA-A1 protein 0.2ml
SLC27A2 英文名稱： 長鏈脂肪酸輔酶A連接酶抗體 0.1ml
FSTL5 英文名稱： 卵泡抑素相關蛋白5抗體 0.2ml
Rhesus antibody Rh Phospho-Pin1 (Ser16) 磷酸化肽基脯氨酞順反異構酶Pinl抗體 規(guī)格 0.1ml
IGF-II( Insulin-like Growth Factor-II ) 樣生長因子-II(抗原)Multi-class antibodies規(guī)格： 0.5mg
LIF 大鼠抑制因子Multi-class antibodies規(guī)格： 48T
Anti-ECP 嗜酸性粒細胞陽離子蛋白抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh MYPT1/MBS 肌球蛋酸酶抗體 規(guī)格 0.1ml
FPA(Human fibrinopeptide A) ELISA Kit 人血纖肽/纖維蛋白肽A 96T
SOX1 英文名稱： 核轉錄因子抗體 0.2ml
CCL21 英文名稱： 淋巴細胞趨化因子CCL21抗體 0.1ml
Anti-ECP 嗜酸性粒細胞陽離子蛋白抗體Multi-class antibodies規(guī)格： 0.2ml
溶菌酶5g炭疽桿菌檢測用配套試劑
FRASER Listeria Selective Enrichment Broth( base) 1.10398.0500 MERCK默克 incubation media FRASER Listeria Selective Enrichment Broth( base) 1.10398.0500 MERCK默克
改良EC新生霉素增菌肉湯基礎(mEC+n) 250g 用于致病性大腸桿菌O157:H7的增菌培養(yǎng)(GB/T 4789.36-2008, SN/T 1827-2006和SN/T0973-2000)。
兔骨髓間質干細胞成軟骨誘導分化完全培養(yǎng)基Rabbitbonemarrowmesenchymalstemcellsintochondrocytesinduceddifferentiationofcompletemedium
UBA培養(yǎng)基 250g 用于啤酒中厭氧菌檢測
芽孢桿菌培養(yǎng)基250g用于芽孢桿菌平板計數(shù)
李斯特菌鑒定顯色培養(yǎng)基 用于將李斯特菌鑒定到種 250ml incubation media 李斯特菌鑒定顯色培養(yǎng)基 用于將李斯特菌鑒定到種 250ml
類干酪乳桿菌類干酪亞種 支/瓶
LST發(fā)酵管(含小倒管)20支/包用于大腸菌群、大腸桿菌的測定
LactoseBileBroth
環(huán)指蛋白139抗體費用 1%NaCl甘露糖 規(guī)格： 20支/盒 用途： 用于鑒別耐的弧菌利用糖源的能力。（鑒定霍亂弧菌）
葡萄糖磷酸鹽胨水生化鑒定管 規(guī)格： 20支/盒 用途： 細菌生化鑒定
1%NaCl甘露醇生化鑒定管 規(guī)格： 20支/盒 用途： 用于鑒別耐的弧菌利用糖源的能力。（鑒定霍亂弧菌）
蛋白胨水生化鑒定管 規(guī)格： 20支/盒 用途： 細菌生化鑒定
